COPD - Nationale VersorgungsLeitlinien

33. Kauffmann F, Drouet D, Lellouch J, Brille D. Twelve years spirometric changes among Paris area
workers. Int J Epidemiol 1979;8(3):201-12.
34. Holt PG. Immune and inflammatory function in cigarette smokers. Thorax 1987;42(4):241-9.
35. Dayal HH, Khuder S, Sharrar R, Trieff N. Passive smoking in obstructive respiratory disease in an
industrialized urban population. Environ Res 1994;65(2):161-71.
36. Leuenberger P, Schwartz J, Ackermann-Liebrich U, Blaser K, Bolognini G, Bongard JP, Brandli O,
Braun P, Bron C, Brutsche M. Passive smoking exposure in adults and chronic respiratory symptoms
(SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. Am
J Respir Crit Care Med 1994;150(5 Pt 1):1222-8.
37. US Department of Health and Human Services. The health consequences of smoking. Chronic
obstructive pulmonary disease. A report of the Surgeon General. Washington: 1984 [cited: 2005 Jul
07]. Available from: http://profiles.nlm.nih.gov/NN/B/C/C/S/_/nnbccs.pdf
38. Behera D,Jindal SK. Respiratory symptoms in Indian women using domestic cooking fuels. Chest
1991;100(2):385-8.
39. O'Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with
"irreversible" emphysema. Eur Respir J 2001;18(6):914-20.
40. Begin P,Grassino A. Inspiratory muscle dysfunction and chronic hypercapnia in chronic obstructive
pulmonary disease. Am Rev Respir Dis 1991;143(5 Pt 1):905-12.
41. Baldi S, Miniati M, Bellina CR, Battolla L, Catapano G, Begliomini E, Giustini D, Giuntini C.
Relationship between extent of pulmonary emphysema by high-resolution computed tomography and
lung elastic recoil in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med
2001;164(4):585-9.
42. Georgopoulos D, Anthonisen NR. Symptoms and signs of COPD. In: Cherniack NS, editor. Chronic
obstructive pulmonary disease Toronto: Saunders; 1991. p. 357-63.
43. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in
adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-
1994. Arch Intern Med 2000;160(11):1683-9.
44. Thurlbeck WM,Simon G. Radiographic appearance of the chest in emphysema. AJR Am J
Roentgenol 1978;130(3):429-40.
45. Taube C, Lehnigk B, Paasch K, Kirsten DK, Jorres RA, Magnussen H. Factor analysis of changes in
dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary
disease. Am J Respir Crit Care Med 2000;162(1):216-20.
46. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic
hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic
obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163(6):1395-9.
47. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance
after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med
1999;160(2):542-9.
48. O'Donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance
during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158(5 Pt
1):1557-65.
49. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of
exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med
2000;161(5):1608-13.
81
© 2006